English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/122399
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Animal model for identifying therapetucually useful compounds for the treatment of sporadic amyotrophic lateral sclerosis

Other TitlesModelo animal para identificar compuestos terapéuticamente útiles para el tratamiento de la esclerosis lateral amiotrófica esporádica
AuthorsGil, Carmen ; Martínez, Ana
Issue Date23-Jan-2014
CitationWO2014013104 A1
Abstract[EN] The invention relates to a method for identifying compounds that are potentially useful for the treatment of sporadic amyotrophic lateral sclerosis (ALS), comprising the use of an animal model of rats, developed by means of the administration of β-Ν-methylamino-L-alanine (L-BMAA)
[ES] La presente invención se refiere a un método para la identificación de compuestos potencialmente útiles para el tratamiento de la Esclerosis Lateral Amiotrofica (ELA) esporádica que comprende el empleo de un modelo animal de ratas desarrollado mediante la administración de β-Ν-metilamino-L-alanina (L-BMAA)
Appears in Collections:(CIB) Patentes
Files in This Item:
File Description SizeFormat 
WO2014013104A1.pdf1,75 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.